Topkan, E.; Senyurek, S.; Kılic Durankus, N.; Ozturk, D.; Selek, U.
Novel Somay’s GLUCAR Index Efficiently Predicts Survival Outcomes in Locally Advanced Pancreas Cancer Patients Receiving Definitive Chemoradiotherapy: A Propensity-Score-Matched Cohort Analysis. J. Pers. Med. 2024, 14, 746.
https://doi.org/10.3390/jpm14070746
AMA Style
Topkan E, Senyurek S, Kılic Durankus N, Ozturk D, Selek U.
Novel Somay’s GLUCAR Index Efficiently Predicts Survival Outcomes in Locally Advanced Pancreas Cancer Patients Receiving Definitive Chemoradiotherapy: A Propensity-Score-Matched Cohort Analysis. Journal of Personalized Medicine. 2024; 14(7):746.
https://doi.org/10.3390/jpm14070746
Chicago/Turabian Style
Topkan, Erkan, Sukran Senyurek, Nulifer Kılic Durankus, Duriye Ozturk, and Ugur Selek.
2024. "Novel Somay’s GLUCAR Index Efficiently Predicts Survival Outcomes in Locally Advanced Pancreas Cancer Patients Receiving Definitive Chemoradiotherapy: A Propensity-Score-Matched Cohort Analysis" Journal of Personalized Medicine 14, no. 7: 746.
https://doi.org/10.3390/jpm14070746
APA Style
Topkan, E., Senyurek, S., Kılic Durankus, N., Ozturk, D., & Selek, U.
(2024). Novel Somay’s GLUCAR Index Efficiently Predicts Survival Outcomes in Locally Advanced Pancreas Cancer Patients Receiving Definitive Chemoradiotherapy: A Propensity-Score-Matched Cohort Analysis. Journal of Personalized Medicine, 14(7), 746.
https://doi.org/10.3390/jpm14070746
